Galectin-3: A Novel Marker for the Prediction of Stroke Incidence and Clinical Prognosis

Table 2

Association of plasma Gal-3 levels with stroke outcomes.

Ischemic stroke
Dong et al. [46]	Outcome	Sensitivity	Specificity	Cut-off value
	Functional outcome	88.4%	76.9%	53.5 pg/mL
Wang et al. [63]	Outcome	Q1	Q2	Q3	Q4
	Death or major disability (OR)	1.00	1.09	1.16	1.55
	Death (OR)	1.00	0.74	0.81	2.10
	Major disability (OR)	1.00	1.13	1.19	1.43
Haemorrhagic stroke
Yan et al. ([64])	1-week mortality	73.3%	79.4%	28.9 ng/mL
	6-month mortality	90.9%	64.6%	22.4 ng/mL
	6-month unfavourable outcome	89.5%	65.5%	18.9 ng/mL
Liu et al. ([62])	6-month mortality	77.8%	70.6%	24.6 ng/mL
	6-month unfavourable outcome	81.1%	77.1%	23.4 ng/mL

Wang et al. categorized their study participants into 4 subgroups according to the quartiles of Gal-3 levels with Q4 being the highest quartile and Q1 being the lowest one. OR indicates odds ratio.